本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ARS PHARMACEUTICALS INC

5.51
0.0000
盤前5.39-0.1150-2.09%05:58 EDT
成交量:126.79萬
成交額:699.97萬
市值:5.47億
市盈率:-2.53
高:5.60
開:5.52
低:5.47
收:5.51
52周最高:14.00
52周最低:4.91
股本:9,944.73萬
流通股本:4,803.45萬
量比:0.49
換手率:2.64%
股息:- -
股息率:- -
每股收益(TTM):-2.1757
每股收益(LYR):-1.7400
淨資產收益率:-210.35%
總資產收益率:-48.02%
市淨率:43.75
市盈率(LYR):-3.16

資料載入中...

2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

重要事件披露

Form 8-K - Current report
2026/07/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]